Analysis of IL-17(+) cells in facet joints of patients with spondyloarthritis suggests that the innate immune pathway might be of greater relevance than the Th17-mediated adaptive immune response
about
Old and new treatment targets in axial spondyloarthritisReview: The interleukin-23/interleukin-17 axis in spondyloarthritis pathogenesis: Th17 and beyond"The NET Outcome": Are Neutrophil Extracellular Traps of Any Relevance to the Pathophysiology of Autoimmune Disorders in Childhood?New treatment targets for axial spondyloarthritisGeneration and differentiation of induced pluripotent stem cells reveal ankylosing spondylitis risk gene expression in bone progenitorsIdentification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related lociIs secukinumab a safe alternative treatment for ankylosing spondylitis with Guillain Barré syndrome after anti-TNF-α treatment? Case report and literature review.Update on ankylosing spondylitis: current concepts in pathogenesis.Inhibition of aberrant circulating Tfh cell proportions by corticosteroids in patients with systemic lupus erythematosus.Heterogeneous expression pattern of interleukin 17A (IL-17A), IL-17F and their receptors in synovium of rheumatoid arthritis, psoriatic arthritis and osteoarthritis: possible explanation for nonresponse to anti-IL-17 therapy?B cells contribute to heterogeneity of IL-17 producing cells in rheumatoid arthritis and healthy controls.Immune cell transcript modules reveal leukocyte heterogeneity in synovial biopsies of seronegative spondylarthropathy patients.Neutralization of IL-17 ameliorates uveitis but damages photoreceptors in a murine model of spondyloarthritis.Association of cytokine and matrix metalloproteinase profiles with disease activity and function in ankylosing spondylitis.Ankylosing spondylitis patients display altered dendritic cell and T cell populations that implicate pathogenic roles for the IL-23 cytokine axis and intestinal inflammationInflammation-driven bone formation in a mouse model of ankylosing spondylitis: sequential not parallel processes.Non-conventional forms of HLA-B27 are expressed in spondyloarthritis joints and gut tissue.Rebamipide prevents peripheral arthritis and intestinal inflammation by reciprocally regulating Th17/Treg cell imbalance in mice with curdlan-induced spondyloarthritis.A proof-of-concept study with the tyrosine kinase inhibitor nilotinib in spondyloarthritis.17 and 23: prime numbers for ankylosing spondylitis?Increase risk of allergic diseases in patients with ankylosing spondylitis: A 10-year follow-up population-based study in Taiwan.Functional defects in CD4+ CD25high FoxP3+ regulatory cells in ankylosing spondylitis.Review: Enthesitis: New Insights Into Pathogenesis, Diagnostic Modalities, and Treatment.Anti-IL17A in Axial Spondyloarthritis-Where Are We At?T-cell receptor signaling and the pathogenesis of autoimmune arthritis: insights from mouse and man.Endoplasmic reticulum aminopeptidase 1 and interleukin-23 receptor in ankylosing spondylitis.Are spondylarthritides related but distinct conditions or a single disease with a heterogeneous phenotype?Spondyloarthritis in 2012: Advances in pathogenesis through animal models and imaging.Cellular sources of IL-17 in psoriasis: a paradigm shift?Focal bone involvement in inflammatory arthritis: the role of IL17.Emerging drugs for the treatment of axial and peripheral spondyloarthritis.The IL-23-IL-17 axis in inflammatory arthritis.Role of IL-17 in the pathogenesis of psoriatic arthritis and axial spondyloarthritis.Biologics in spondyloarthritis: TNFα inhibitors and other agents.The interleukin (IL)-23/IL-17 axis in ankylosing spondylitis: new advances and potentials for treatment.Mediators of inflammation and bone remodeling in rheumatic disease.Mechanism of New Bone Formation in Axial Spondyloarthritis.Developments with experimental and investigational drugs for axial spondyloarthritis.The Paradox of Bone Formation and Bone Loss in Ankylosing Spondylitis: Evolving New Concepts of Bone Formation and Future Trends in Management.Secukinumab (AIN457) in the treatment of ankylosing spondylitis.
P2860
Q26777906-0C9FEDDB-2DC5-45D6-A46C-6BE3E0B6D9BCQ26991709-7C26121A-637F-4B35-A139-328C5A3C2C24Q28070285-BFB11760-B5EE-4766-986C-78063C526D9BQ28073999-5992E814-8779-4292-AD67-280C535DEF85Q29247925-32D93E82-2F6C-40D7-9459-5BA47D823209Q30417517-7659F874-212D-457C-9829-AF43266D546CQ31165527-0EFC65E5-CEF5-4647-9195-CE90875C9CC7Q34450732-B7FA6717-D6AE-4D1A-9323-D30561E4FEC9Q34532672-DB6690E8-C1FA-4E72-8395-C69F6362A805Q34937925-6E4D9B27-0C52-4FB3-9711-AD0BEE98DA4AQ35067840-E1928765-AB35-462D-9406-544288772A1BQ35531152-D3C83E30-ACF4-4FF3-A41D-C002A18B3319Q36084943-FEE7DEAD-6A1A-4E13-8FC9-50083DC0B2FDQ36246052-0323E0F4-3478-46A4-9B34-3138941505EFQ36366157-02D7B2D1-C505-4A9F-A80A-3D872C032807Q36525920-724B9A47-F56E-4A73-BD28-AC546056E0D9Q36913820-8362047D-6C2D-4503-8B7A-27C11DCA7F43Q37045417-B4B036BA-8B69-4029-8671-17DD7BE492E7Q37369583-1CAC6EEB-CA76-49EC-8BE1-9C7812BCE562Q37378175-F2090D9D-DEA1-4D3E-9EB9-1DBAA5CA463CQ37409527-ED470F45-6178-45EA-936C-AD885C9FD92DQ37454135-A90112E2-897D-47AA-8D58-0C607265DA7DQ37541327-7DCEF1F8-4A31-4916-9A7E-976BFD4FA048Q37590576-1FF5E3C3-189A-46EB-9FB0-540AE4645BA9Q37993692-8224DE5C-7E1E-4495-8276-DBADE57C0649Q38025334-82E79B29-D2AF-43CB-88F5-AD61101753BAQ38071564-B74DE932-5E32-4582-B714-BBD29271A04AQ38072310-73A94B57-B0BF-4BC9-8C81-3BE6979E5DAFQ38231403-B197E0A6-0B9A-4FE4-B9ED-7BF3EA8B4782Q38295616-3493AFF1-D33C-42D9-A1E3-1D664A9E27B7Q38313266-EA22B892-0142-48A1-B3E7-6D37B104BD9AQ38439641-07A89CC8-EDD1-4031-B248-463575E2FCBCQ38458004-90D60FE5-F43A-41D4-B0F6-2644769EC820Q38522331-2F4C3658-1D79-468D-AF4D-DDE6769D1664Q38529525-8C411996-70B9-4BB2-B852-0376180AA9A1Q38576851-6D1A32CD-CAD4-435C-AF67-BCD10928B1CCQ38655991-B3D4E488-3C81-45A2-8E7E-98EC8F6E5F1BQ38676714-7DC0D102-4EE5-4F94-98AF-CF5463280161Q38737389-1CCC912B-6329-492F-8059-CFC74F7615F6Q38777116-A1D89533-92FB-4874-AE66-FDD39F98FE6D
P2860
Analysis of IL-17(+) cells in facet joints of patients with spondyloarthritis suggests that the innate immune pathway might be of greater relevance than the Th17-mediated adaptive immune response
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Analysis of IL-17(+) cells in ...... iated adaptive immune response
@ast
Analysis of IL-17(+) cells in ...... iated adaptive immune response
@en
type
label
Analysis of IL-17(+) cells in ...... iated adaptive immune response
@ast
Analysis of IL-17(+) cells in ...... iated adaptive immune response
@en
prefLabel
Analysis of IL-17(+) cells in ...... iated adaptive immune response
@ast
Analysis of IL-17(+) cells in ...... iated adaptive immune response
@en
P2093
P2860
P356
P1476
Analysis of IL-17(+) cells in ...... iated adaptive immune response
@en
P2093
Andreas Radbruch
Andreas Thiel
Axel Hempfing
Heiner Appel
Joachim Sieper
Ralph Kayser
Rebecca Scheer
René Maier
P2860
P2888
P356
10.1186/AR3370
P577
2011-06-20T00:00:00Z
P5875
P6179
1002060930